Verdad Advisers’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$214K Sell
1,476
-1,007
-41% -$139K 0.23% 146
2026
Q2
$319K Sell
2,483
-3,177
-56% -$372K 0.31% 113
2026
Q1
$681K Sell
5,660
-5,986
-51% -$691K 0.77% 42
2025
Q4
$1.23M Buy
+11,646
New +$1.09M 1.4% 23
2024
Q3
$1.36M Hold
11,988
– – 1.82% 11
2024
Q2
$1.48M Sell
11,988
-224
-2% -$28.9K 1.71% 11
2024
Q1
$1.61M Buy
+12,212
New +$1.51M 1.75% 8

Other funds holding MRK

Verdad Advisers's MRK Position: Q3 2026 in Review

Verdad Advisers reduced its Merck (MRK) stake by 41% in Q3 2026, selling an estimated $139K and leaving 1,476 shares worth $214K. The position accounts for 0.23% of the portfolio, ranked #146.

Verdad Advisers first reported a position in MRK in Q1 2024 and has held it in 7 quarters since. The position peaked at $1.61M in Q1 2024. 3,967 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Verdad Advisers held 1,476 shares of Merck worth $214K as of Q3 2026.
  • Verdad Advisers sold 1,007 Merck shares in Q3 2026, an estimated $139K.
  • Merck made up 0.23% of Verdad Advisers's portfolio in Q3 2026, its #146 holding.
  • Verdad Advisers first reported a position in Merck in Q1 2024 and has held it in 7 quarters since.
  • Verdad Advisers's Merck position peaked at $1.61M in Q1 2024.
  • 3,967 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Verdad Advisers's 13F filing for Q3 2026, filed 16 Nov 2026.